There was a significant reduction in CAPS score over the course of treatment ( F ( 7 , 142 ) = 41.58 , p < 0.001 ) in both the escitalopram and placebo groups , with a greater reduction in CAPS score in the placebo group F ( 7 , 142 ) = 2.12 , p = 0.045 .